COVID-19 Related Acute Macular Neuroretinopathy (AMN): A Case Series

Abstract

Truong Andy Vu,1– 3 Megan Schillerstrom,3,4 Saoul Mancha,3 William Eric Sponsel2,3 1University of the Incarnate Word, School of Osteopathic Medicine, San Antonio, TX, 78235, USA; 2University of the Incarnate Word, Department of Visual Science, San Antonio, TX, 78235, USA; 3Sponsel Eye Experts, San Antonio, TX, 78233, USA; 4Trinity University, Department of Neuroscience, San Antonio, TX, 78212, USACorrespondence: Truong Andy Vu, University of the Incarnate Word School of Osteopathic Medicine, 7615 Kennedy Hill Dr, San Antonio, TX, 78235, USA, Email [email protected]: Following the emergence of coronavirus disease 2019 (COVID-19) eye care practitioners have become accustomed to identifying and managing an array of ocular complications following the viral infection. Acute macular neuroretinopathy (AMN) is one such complication that has been reported. While the etiology of AMN has eluded researchers, current literature is suggestive of a microvascular compromise within the deep capillary plexus of the retina.Observations: In this case series, we aim to explore two individual cases of presumed AMN following confirmed COVID-19 infection. Our observations and findings support the diagnosis of AMN following the criteria outlined in literature.Conclusion and Importance: Although acute macular neuroretinopathy is rare, it should be considered by clinicians when considering diagnosis. With the changing landscape of the pandemic, careful and thorough history and testing are key in the diagnosis of AMN.Keywords: COVID-19, acute macular retinopathy, neuroretinopathy

Keywords

• covid-19
• acute macular retinopathy
• neuroretinopathy